Lori Nelson
Women's Health · Silverdale, WANPI 1902895428
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 33.5% of the total. Reporting peaked in 2023 at $217 and has fallen 59.4% since, to $88 in 2025.
Across 30 payments — averaging $21.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$219
- Mayne Pharma Commercial LLC$111
- Agile Therapeutics, Inc.$103
- Hologic Sales And Service, LLC$45
- Myovant Sciences Inc.$40
- Exact Sciences$32
- plus $105 from 5 others
What the payments were for
- Food & beverage$654100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $219 |
| Mayne Pharma Commercial LLC | 6 | $111 |
| Agile Therapeutics, Inc. | 5 | $103 |
| Hologic Sales And Service, LLC | 2 | $45 |
| Myovant Sciences Inc. | 2 | $40 |
| Exact Sciences | 1 | $32 |
| Biosense Webster, Inc. | 1 | $29 |
| Avion Pharmaceuticals | 1 | $21 |
| Optumhealth Care Solutions, LLC | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Exeltis, USA Inc. | 1 | $18 |
How this compares
$654 in reported general payments places this provider in the 70th percentile of 101 women's health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 172 | $18,196 |
| YuvafemEstradiol | 19 | $4,028 |
| Estradiol (Once Weekly)Estradiol | 29 | $2,120 |
| ProgesteroneProgesterone, Micronized | 54 | $1,766 |
| Clobetasol Propionate | 24 | $848 |
| Norethindrone Acetate | 18 | $676 |
| Fluconazole | 24 | $120 |
Paid to pharmacies, not to this prescriber.
Other women's health in Silverdale
- Tamara TobiasBellevue$30K
- Rachel FidinoKennewick$28K
- Anna AlstonSeattle$13K
- Lisa Kent AbelBellevue$5K
- Kendra JohnsonSpokane Valley$4K
- Fasadinah ManaloSeattle$3K
- Kenna LeisSunnyside$3K
- Andrea StevensKirkland$3K
- Brenda StavishBurien$2K
- Megan BedkerMercer Island$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.